Mandate

Vinge Advises Tech Data on the Acquisition of Scribona Assets

March 11, 2008

Vinge represents Tech Data in connection to the acquisition of Scribona’s assets in Sweden, Finland and Norway. The business deal, which was made official on March the 4th, is conditioned by the approval of Scribona’s shareholders, which annual general meeting will take place on the 29th of April, but also by the approval of the competition authority of the European Union.   

Tech Data is listed on NASDAQ and it is one of the world’s largest distributors of Information Technology, it has an estimated revenue of USD 23 billion. Scribona is listed on Small Cap on OMX Nordic Exchange and one of Sweden, Finland and Norway’s leading distributors of Information Technology products. Scribona’s revenue has an approximate value of SEK 8 billions. Tech Data will, by the acquisition, become the largest distributor of Information Technology in the Nordic countries.

Partners Ulf Sallnäs (M&A), Fredrik Dahl (Employment) and Johan Karlsson (Antitrust) joined by associates Martin Hall (M&A), Emma Olsson (Employment) as well as Peter Alstergren and economist Mattias Ganslandt (Antitrust) made up Vinge’s team.      

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025